These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


237 related items for PubMed ID: 19070892

  • 21. Insulin-like growth factor (IGF)-I and insulin in normal and growth-restricted mother/infant pairs.
    Malamitsi-Puchner A, Briana DD, Gourgiotis D, Boutsikou M, Puchner KP, Baka S, Marmarinos A, Hassiakos D.
    Mediators Inflamm; 2007; 2007():42646. PubMed ID: 17497031
    [Abstract] [Full Text] [Related]

  • 22. Intrauterine growth restriction is associated with alterations in placental lipoprotein receptors and maternal lipoprotein composition.
    Wadsack C, Tabano S, Maier A, Hiden U, Alvino G, Cozzi V, Hüttinger M, Schneider WJ, Lang U, Cetin I, Desoye G.
    Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E476-84. PubMed ID: 17003234
    [Abstract] [Full Text] [Related]

  • 23. Methemoglobin levels in umbilical cord blood of women with intrauterine growth restriction and preeclampsia.
    Yusuf K, Wilson RD, Kamaluddeen M, Franta J, Hasan SU, Akierman A.
    J Matern Fetal Neonatal Med; 2014 May; 27(8):789-94. PubMed ID: 23998850
    [Abstract] [Full Text] [Related]

  • 24. Prenatal smoking exposure and asymmetric fetal growth restriction.
    Delpisheh A, Brabin L, Drummond S, Brabin BJ.
    Ann Hum Biol; 2008 May; 35(6):573-83. PubMed ID: 18932054
    [Abstract] [Full Text] [Related]

  • 25. A modification of the uterine artery restriction technique in the guinea pig fetus produces asymmetrical ultrasound growth.
    Turner AJ, Trudinger BJ.
    Placenta; 2009 Mar; 30(3):236-40. PubMed ID: 19121541
    [Abstract] [Full Text] [Related]

  • 26. The role of the anti-angiogenic factor endostatin in intrauterine growth restriction.
    Malamitsi-Puchner A, Boutsikou T, Economou E, Makrakis E, Iliodromiti Z, Kouskouni E, Hassiakos D.
    J Soc Gynecol Investig; 2005 Apr; 12(3):195-7. PubMed ID: 15784505
    [Abstract] [Full Text] [Related]

  • 27. Intrauterine growth restriction and the proliferation of smooth muscle cells in umbilical vessels.
    Yoshimatsu J, Goto K, Nasu K, Narahara H, Miyakawa I.
    Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):212-6. PubMed ID: 16704475
    [Abstract] [Full Text] [Related]

  • 28. Comparison of fetal and neonatal growth curves in detecting growth restriction.
    Marconi AM, Ronzoni S, Bozzetti P, Vailati S, Morabito A, Battaglia FC.
    Obstet Gynecol; 2008 Dec; 112(6):1227-1234. PubMed ID: 19037030
    [Abstract] [Full Text] [Related]

  • 29. Amniotic IGF-I supplements improve gut growth but reduce circulating IGF-I in growth-restricted fetal sheep.
    Bloomfield FH, Bauer MK, van Zijl PL, Gluckman PD, Harding JE.
    Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E259-69. PubMed ID: 11788356
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Increased arterial stiffness and extracellular matrix reorganization in intrauterine growth-restricted fetal sheep.
    Dodson RB, Rozance PJ, Fleenor BS, Petrash CC, Shoemaker LG, Hunter KS, Ferguson VL.
    Pediatr Res; 2013 Feb; 73(2):147-54. PubMed ID: 23154756
    [Abstract] [Full Text] [Related]

  • 32. Cationic amino acid transporter activity in the syncytiotrophoblast microvillous plasma membrane and oxygenation of the uteroplacental unit.
    Radaelli T, Cetin I, Ayuk PT, Glazier JD, Pardi G, Sibley CP.
    Placenta; 2002 Apr; 23 Suppl A():S69-74. PubMed ID: 11978061
    [Abstract] [Full Text] [Related]

  • 33. Maternal and fetal blood levels of S100 and ischaemia modified albumin in term intrauterine growth restricted fetuses with abnormal umbilical artery Doppler values.
    Kiseli M, Caglar GS, Gursoy AY, Ozdemir ED, Ozdemir H, Seker RT, Demirtas S.
    J Obstet Gynaecol; 2015 May; 35(4):368-71. PubMed ID: 25384244
    [Abstract] [Full Text] [Related]

  • 34. Cord blood cortisol level is lower in growth-restricted newborns.
    Strinic T, Roje D, Marusic J, Capkun V.
    J Obstet Gynaecol Res; 2007 Apr; 33(2):144-50. PubMed ID: 17441886
    [Abstract] [Full Text] [Related]

  • 35. Maternal serum ferritin as a clinical tool at 34-36 weeks' gestation for distinguishing subgroups of fetal growth restriction.
    Akkurt MO, Akkurt I, Altay M, Coskun B, Erkaya S, Sezik M.
    J Matern Fetal Neonatal Med; 2017 Feb; 30(4):452-456. PubMed ID: 27049175
    [Abstract] [Full Text] [Related]

  • 36. Intrauterine growth restriction is associated with changes in polyunsaturated fatty acid fetal-maternal relationships.
    Cetin I, Giovannini N, Alvino G, Agostoni C, Riva E, Giovannini M, Pardi G.
    Pediatr Res; 2002 Nov; 52(5):750-5. PubMed ID: 12409524
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Umbilical cord serum levels of insulin-like growth factor-1, insulin and growth hormone in neonates with intrauterine growth retardation].
    Zhao P, Zhang XL, Yu C, Lu XY, Wang YM.
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Oct; 12(10):771-3. PubMed ID: 20959038
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.